|
|
Article: Medical Science Systems and University of Sheffield Joint Research Links New Gene Sequence With Control of Inflammatory Diseases.
- Article from:
- Business Wire
- Article date:
- March 9, 1999
CopyrightCOPYRIGHT 1999 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN ANTONIO--(BW HealthWire)--March 9, 1999--Medical Science Systems, Inc. (Nasdaq Small Cap:MSSI) announced today it has filed for patent protection for a new gene sequence and its function. This sequence is in the chromosome region known to regulate interleukin-1 (IL-1) cytokine production and levels. Individuals who have this gene sequence have been shown to produce significantly higher levels of IL-1. Interleukin-1 plays a major role in the inflammatory response, the immune response, and bone and connective tissue metabolism. This research and related patent filings is the result of joint research and development on the genetic factors of inflammatory diseases between ...
Related newspaper, magazine, and journal articles:
|
|
Article: Medical Science Systems Announces Second ...
Business Wire;
July 12, 1999 ;
700+ words
... ... July 12, 1999-- Medical Science Systems, Inc. (NASDAQ: MSSI ... Chief Scientific Officer for Medical Science Systems. The results of the study ... investigation by MSSI. Medical Science Systems, Inc. develops and commercializes ...
|
|